In last trading session, Lucid Diagnostics Inc (NASDAQ:LUCD) saw 0.82 million shares changing hands with its beta currently measuring 1.24. Company’s recent per share price
Lucid Diagnostics Inc (NASDAQ:LUCD) has a beta value of 1.21 and has seen 1.17 million shares traded in the last trading session. The company, currently
Lucid Diagnostics Inc (NASDAQ:LUCD)’s traded shares stood at 1.08 million during the last session, with the company’s beta value hitting 1.28. At the close of
In the last trading session, 1.29 million Lucid Diagnostics Inc (NASDAQ:LUCD) shares changed hands as the company’s beta touched 1.27. With the company’s per share
During the last session, Lucid Diagnostics Inc (NASDAQ:LUCD)’s traded shares were 0.78 million, with the beta value of the company hitting 1.36. At the end
In the last trading session, 2.62 million Lucid Diagnostics Inc (NASDAQ:LUCD) shares changed hands as the company’s beta touched 1.07. With the company’s per share
In the latest trading session, 0.79 million Lucid Diagnostics Inc (NASDAQ:LUCD) shares changed hands as the company’s beta touched 1.07. With the company’s most recent
During the last session, Lucid Diagnostics Inc (NASDAQ:LUCD)’s traded shares were 0.69 million, with the beta value of the company hitting 1.25. At the end
In the last trading session, 1.83 million shares of the Lucid Diagnostics Inc (NASDAQ:LUCD) were traded, and its beta was 1.27. Most recently the company’s
In the last trading session, 1.07 million shares of the Lucid Diagnostics Inc (NASDAQ:LUCD) were traded, and its beta was 1.25. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
